Compounds > reboxetine
Page last updated: 2024-09-03

reboxetine and Cataleptic Attacks

reboxetine has been researched along with Cataleptic Attacks in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brunner, H; Friess, E; Pollmächer, T; Wichniak, A1
Gonzalez-Arriaza, HL; Krahn, LE1
Bario, S; de la Llave, Y; Garcia-Borreguero, D; Granizo, JJ; Larrosa, O1

Other Studies

3 other study(ies) available for reboxetine and Cataleptic Attacks

ArticleYear
Successful suppression of cataplectic attacks with tramadol.
    Neurology, 2003, Sep-23, Volume: 61, Issue:6

    Topics: Aged; Biogenic Monoamines; Cataplexy; Female; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Morpholines; Narcotics; Reboxetine; Receptors, Opioid; Recurrence; Sleep, REM; Substance Withdrawal Syndrome; Tramadol; Tranylcypromine; Treatment Outcome

2003
Narcolepsy with cataplexy.
    The American journal of psychiatry, 2004, Volume: 161, Issue:12

    Topics: Adult; Cataplexy; Comorbidity; Cyclohexanols; Hallucinations; Humans; Male; Morpholines; Narcolepsy; Patient Education as Topic; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sodium Oxybate; Venlafaxine Hydrochloride

2004
Stimulant and anticataplectic effects of reboxetine in patients with narcolepsy: a pilot study.
    Sleep, 2001, May-01, Volume: 24, Issue:3

    Topics: Adult; Antidepressive Agents; Cataplexy; Female; Humans; Male; Morpholines; Narcolepsy; Pilot Projects; Reboxetine; Severity of Illness Index; Sleep Stages

2001